Cornec-Le Gall et al. developed the PROPKD Score, a model that combines clinical factors, such as the onset of hypertension, with genetic data, specifically PKD1 and PKD2 mutation types, to stratify patients into risk categories and provide a more accurate prognosis for renal survival [19]. This evidence concerns the gene PKD1 and hypertensive disorder.